GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,400.00
Bid: 2,380.00
Ask: 2,420.00
Change: -70.00 (-2.92%)
Spread: 40.00 (1.681%)
Open: 2,420.00
High: 2,330.00
Low: 2,330.00
Prev. Close: 2,330.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of SAYE Options, Director Dealing & TVR

1 Nov 2023 14:38

RNS Number : 0859S
Craneware plc
01 November 2023
 

Craneware plc

("Craneware" or the "Company")

 

Exercise of SAYE Options, Director Dealing

and Total Voting Rights

 

1 November 2023 - The Board of Craneware plc (AIM: CRW.L), the market leader in automated Value Cycle solutions for the US healthcare market, announces that on 31 October 2023, options over ordinary shares of 1p each in the Company ("Ordinary Shares") were exercised under the terms of the Craneware plc SAYE Option Plan (2018) by certain employees and Directors (the "SAYE Options" and together, the "Exercise").

 

Included within the Exercise was an aggregate of 3,136 SAYE Options exercised by the following Directors:

 

Director

Number of SAYE Options exercised

Exercise price

(per Ordinary Share)

SAYE Options as a percentage of total voting rights of the Company

 

Keith Neilson (CEO)

 

1,568

 

1,147.5 pence

 

0.004%

 

Craig Preston (CFO)

 

1,568

 

1,147.5 pence

 

0.004%

 

Following this transaction, Keith Neilson holds 3,467,707 Ordinary Shares, representing 9.81% of the total voting rights of the Company and Craig Preston holds 100,417 Ordinary Shares representing 0.28% of the total voting rights of the Company, as described below.

 

Total Voting Rights

 

Following the Exercise and also the earlier exercise of SAYE Options and receipt of employee vested share plan awards by certain other employees in the period since 16 October 2023, the Company is transferring or has transferred a total of 13,380 Ordinary Shares previously held in treasury to satisfy the transactions. As a result, the Company's issued share capital now consists of 35,542,169 Ordinary Shares, of which 179,082 remain held in treasury. Accordingly, the total number of Ordinary Shares in the Company with voting rights is 35,363,087. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

 

PDMR notification: Keith Neilson

 

1. Details of the Restricted Person / person closely associated with him or her

a) Name Keith Neilson

 

2. Reason for the notification

a) Position / status CEO

b) Initial notification / Amendment Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Craneware plc

b) LEI 213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code ISIN GB00B2425G68

 

c) Nature of the transaction Exercise of options over Ordinary Shares

 

d) Price(s) and volume(s) Volume(s) 1,568 , Price(s) £11.475

 

e) Aggregated information: N/A (single transaction)

i. Aggregated volume -

ii. Price(s) -

f) Date of the transaction 2023-10-31

 

g) Place of the transaction Outside a trading venue

 

 

PDMR notification: Craig Preston

 

1. Details of the Restricted Person / person closely associated with him or her

a) Name Craig Preston

 

2. Reason for the notification

a) Position / status CFO

b) Initial notification / Amendment Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Craneware plc

b) LEI 213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code ISIN GB00B2425G68

 

c) Nature of the transaction Exercise of options over Ordinary Shares

 

d) Price(s) and volume(s) Volume(s) 1,568, Price(s) £11.475

 

e) Aggregated information: N/A (single transaction)

i. Aggregated volume -

ii. Price(s) -

 

f) Date of the transaction 2023-10-31

 

g) Place of the transaction Outside a trading venue

 

 

 

For further information, please contact:

 

Craneware plc +44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

 

Alma (Financial PR) +44 (0)20 3405 0205

Caroline Forde, Joe Pederzolli, Kinvara Verdon craneware@almastrategic.com

Peel Hunt (NOMAD and Joint Broker) +44 (0)20 7418 8900

Neil Patel, Paul Gillam, Richard Chambers, Kate Bannatyne

Investec Bank PLC (Joint Broker) +44 (0)20 7597 5970

Patrick Robb, Henry Reast, Cameron MacRitchie

Berenberg (Joint Broker) +44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons

 

About Craneware

The Craneware Group (AIM:CRW.L), the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. Trisus Chargemaster secured top ranking in the Chargemaster Management category of the "2023 Best in KLAS Awards: Software & Services" and is part of an extensive value cycle management suite. The Craneware Group - transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKDBNQBDDADK
Date   Source Headline
5th Mar 201011:02 amRNSDividend Currency Election
22nd Feb 20107:01 amRNSContract Win
22nd Feb 20107:00 amRNSInterim Results
4th Feb 20105:17 pmRNSHolding(s) in Company
25th Jan 201012:49 pmRNSHolding(s) in Company
18th Jan 20107:00 amRNSTrading Update
23rd Dec 20097:01 amRNSGrant of Options
22nd Dec 20097:00 amRNSIntermountain Healthcare Selects Craneware
19th Nov 20093:11 pmRNSResult of AGM
19th Nov 20097:00 amRNSAGM Statement
6th Nov 20091:41 pmRNSDividend Currency Election
21st Oct 20092:46 pmRNSBlocklisting Interim Review
20th Oct 20097:00 amRNSNotice of AGM
1st Oct 200912:39 pmRNSPosting of Annual Report and Accounts
25th Sep 20097:00 amRNSContract Win
18th Sep 200911:51 amRNSDirector/PDMR Shareholding
7th Sep 20097:00 amRNSFinal Results
26th Aug 20097:00 amRNSNotice of Results
6th May 20097:00 amRNSDividend Currency Election
27th Apr 20097:00 amRNSAppointment of Non-Executive Director
16th Apr 200912:44 pmRNSBlocklisting Interim Review
14th Apr 20097:00 amRNSAgreement with US healthcare alliance
26th Mar 200911:01 amRNSDirector/PDMR Shareholding
26th Mar 20097:00 amRNSDividend Declaration
27th Feb 20092:43 pmRNSDirector Shareholding
23rd Feb 20097:00 amRNSInterim Results
11th Feb 20096:23 pmRNSHolding(s) in Company
29th Jan 20097:00 amRNSNotice of Results
13th Jan 20097:00 amRNSTrading Update and Contract Win
19th Nov 200811:10 amRNSHolding(s) in Company
13th Nov 20085:43 pmRNSHolding(s) in Company
7th Nov 20083:04 pmRNSDividend Currency Election
4th Nov 20087:00 amRNSAGM Statement
31st Oct 20081:43 pmRNSHolding(s) in Company
31st Oct 20081:42 pmRNSHolding(s) in Company
24th Oct 200811:28 amRNSBlocklisting Interim Review
13th Oct 20087:00 amRNSNotice of AGM
16th Sep 20085:20 pmRNSHolding(s) in Company
15th Sep 20083:58 pmRNSHolding(s) in Company
9th Sep 20087:01 amRNSAppointment of a Director
9th Sep 20087:00 amRNSFinal Results
10th Jul 20087:00 amRNSTrading Statement
26th Jun 20088:32 amRNSRe Contract
25th Jun 20083:51 pmRNSHolding(s) in Company
24th Jun 20088:34 amRNSContract with CHE
5th Jun 200812:48 pmRNSBlocklisting Interim Review
4th Jun 200812:53 pmRNSHolding(s) in Company
29th May 20087:00 amRNSAppointment of Vice President
26th Feb 20087:01 amRNSInterim Results
8th Feb 20087:00 amRNSNotice of Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.